The current valuation score of Rigel Pharmaceuticals Inc is 8.48, ranking 81 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 1.88, which is 1203.49% below the recent high of 24.52 and 6019.47% above the recent low of -111.36.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.